Stock Ratings | With the stock potentially rising as much as 1292.41%, Guggenheim maintained its "Buy" recommendation on InflaRx (IFRX) and raised its price target from $10 to $22.
Sahm Platform 11/11 09:18
'FTC Denies Sheffield's Petition to Reopen and Set Aside the Exxon-Pioneer Final Order' - FTC
Exxon Mobil Corporation XOM | 0.00 |
https://www.ftc.gov/news-events/news/press-releases/2025/07/ftc-denies-sheffields-petition-reopen-set-aside-exxon-pioneer-final-order
